BriaCell Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is August - July.

Millions USD. Fiscal year is Aug - Jul.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct '25 Oct 31, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022	Jul '21 Jul 31, 2021	Jul '20 Jul 31, 2020
Cash & Equivalents	1.93	0.86	21.25	41.04	57.27	0.02
Short-Term Investments	5.31	-	-	-	-	-
Cash & Short-Term Investments	7.24	0.86	21.25	41.04	57.27	0.02
Cash Growth	739.98%	-95.94%	-48.22%	-28.34%	269412.38%	-86.47%
Accounts Receivable	0.83	2.79	5.7	0.02	0.01	0.02
Other Current Assets	-	-	-	1.28	0.52	0.22
Total Current Assets	8.08	3.65	26.95	42.35	57.8	0.26
Net Property, Plant & Equipment	0.19	0.39	-	-	-	-
Other Intangible Assets	0.13	0.2	0.22	0.23	0.25	0.26
Long-Term Investments	0.39	0.42	0	0	0	0
Other Long-Term Assets	0.51	1.21	-	-	-	-
Total Assets	9.3	5.87	27.16	42.58	58.04	0.52
Accounts Payable	1.51	7.17	1.12	0.46	0.21	3.71
Accrued Expenses	0.85	0.29	0.68	0.48	0.34	-
Short-Term Debt	-	-	-	-	-	0.25
Total Current Liabilities	2.36	7.46	1.8	0.94	0.56	3.96
Long-Term Debt	-	-	-	-	0.03	0.16
Other Long-Term Liabilities	0.29	1.1	29.14	31.31	29.79	-
Total Long-Term Liabilities	0.29	1.1	29.14	31.31	29.82	0.16
Total Liabilities	2.65	8.56	30.94	32.25	30.37	4.12
Common Stock	72.4	72.17	69.59	65.59	54.77	12.26
Additional Paid-in Capital	20.16	11.03	7.42	5.23	2.18	2.45
Accumulated Other Comprehensive Income	-0.1	-0.14	-0.14	-0.14	-0.14	-0.14
Retained Earnings	-85.36	-85.44	-80.65	-60.35	-29.14	-18.17
Total Common Shareholders' Equity	7.1	-2.38	-3.78	10.33	27.67	-3.6
Minority Interest	-0.45	-0.3	-	-	-	-
Shareholders' Equity	6.65	-2.68	-3.78	10.33	27.67	-3.6
Total Liabilities & Equity	9.3	5.87	27.16	42.58	58.04	0.52
Total Debt	-	0	0	0	0.03	0.41
Net Cash (Debt)	7.24	0.86	21.25	41.04	57.24	-0.38
Net Cash Growth	739.98%	-95.94%	-48.22%	-28.30%	-	-
Net Cash Per Share	10.71	7.86	204.08	397.33	1899.82	-80.79
Book Value	7.1	-2.38	-3.78	10.33	27.67	-3.6
Book Value Per Share	10.50	-21.72	-36.27	100.00	918.39	-755.88
Tangible Book Value	6.97	-2.58	-3.99	10.1	27.43	-3.86
Tangible Book Value Per Share	10.31	-23.54	-38.34	97.77	910.24	-810.69

Updated Oct 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.